25/02/2019 19:30:08

CLASS ACTION UPDATE for YRIV, ALKS, MKL and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

Yangtze River Port and Logistics Limited (NASDAQGS: YRIV)

Class Period: February 2, 2016 - December 5, 2018

Lead Plaintiff Deadline: March 4, 2019

Join the action: https://www.zlk.com/pslra-1/yangtze-river-port-and-logistics-ltd-loss-form?wire=3

The lawsuit alleges: Yangtze River Port and Logistics Limited made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Yangtze’s purported lease of the Wuhan Yangtze River Newport Logistics  Center, the Company’s main asset, was a fabrication; (2) Yangtze’s only operating subsidiary, Wuhan Newport, was declared insolvent in China due to a number of default judgments against it; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or  lacked a reasonable basis at all relevant times.

To learn more about the Yangtze River Port and Logistics Limited class action contact jlevi@levikorsinsky.com.

Alkermes plc (NASDAQGS: ALKS)

Class Period: February 17, 2017 - November 1, 2018

Lead Plaintiff Deadline: February 25, 2019

Join the action: https://www.zlk.com/pslra-1/alkermes-plc-loss-form?wire=3

The lawsuit alleges that, during the class period, Alkermes plc made materially false and/or misleading statements and/or failed to disclose that: (1) the FDA had advised Alkermes to follow a certain protocol in connection with its New Drug Application submission for its drug ALKS 5461; (2) Alkermes had failed to follow that protocol; (3) consequently, an FDA advisory committee voted 21 to 2 against the approval of ALKS 5461; and (4) as a result, Alkermes’ public statements were materially false and/or misleading at all relevant times.

To learn more about the Alkermes plc class action contact jlevi@levikorsinsky.com.

Markel Corporation (NYSE: MKL)

Class Period: July 26, 2017 - December 6, 2018

Lead Plaintiff Deadline: March 12, 2019

Join the action: https://www.zlk.com/pslra-1/markel-corporation-loss-form?wire=3

The lawsuit alleges: Markel Corporation made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) the Company’s subsidiaries did not appropriately record loss reserves; (2) as a result, the loss reserves would need to be adjusted and/or restated; (3) these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more about the Markel Corporation class action contact jlevi@levikorsinsky.com.

Avon Products, Inc. (NYSE: AVP)

Class Period: August 2, 2016 - August 2, 2017

Lead Plaintiff Deadline: April 15, 2019

Join the action: https://www.zlk.com/pslra-1/avon-products-inc-loss-form?wire=3

In order to inflate its reported revenue and representative growth metric during the Class Period, Avon engaged in an undisclosed scheme whereby it significantly loosened its credit terms in order to recruit new representatives in Brazil, its largest market. Avon did not disclose the changes to its credit terms in Brazil. Avon also failed to increase its allowance for doubtful accounts to account for the changes to its credit terms in Brazil.

To learn more about the Avon Products, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com 

250x148_zlk.jpg

Related content
12 Jul - 
BKS, EE, AVP and TSS SHAREHOLDER ALERT: Rigrodsky & Lon..
12 Jul - 
Investor Rights Alert: Halper Sadeh LLP Continues Inves..
25 Jun - 
SFLY, BID and AVP SHAREHOLDER ALERT: Rigrodsky & Long, ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Issue of Equity
2
Transaction in Own Shares
3
End of Day
4
Issue of Equity
5
Issue of Equity

Related stock quotes

Avon Products Inc 3.860 -1.5% Stock price decreasing
Markel Corporation 1,086.32 0.6% Stock price increasing
Alkermes PLC - Ordinary .. 22,80 -0.1% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 July 2019 23:48:39
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB4 - 2019-07-24 00:48:39 - 2019-07-23 23:48:39 - 1000 - Website: OKAY